We discovered a p53 activator(MANIO) with safe toxicity in cumulative application on mice skin and great in vitro and in vivo protection against UVR-induced skin damage. We aim to establish a new product to reduce the incidence, progression, and relapse of UVR-related skin disorders by targeting p53